NYSBA Annual Meeting: FDA and Patents? FDA’s Letter to the USPTO and Possible Next Steps | McDermott Skip to main content

NYSBA Annual Meeting: FDA and Patents? FDA’s Letter to the USPTO and Possible Next Steps

NYSBA Annual Meeting: FDA and Patents? FDA’s Letter to the USPTO and Possible Next Steps

Overview


Brian Malkin joins the New York State Bar Association (NYSBA) for their “Annual Meeting Virtual Conference.” Brian will join their “Food, Drug & Cosmetic Law Section” to discuss “FDA and Patents? FDA’s Letter to the USPTO and Possible Next Steps.” MCLE credits available.

Learn more and register here.

Dig Deeper

Webinar / Webinar / February 25, 2026

ISO 13485 Compliance for Medical Device Companies

Webinar / Speaking Engagements / January 22, 2026

HIPAA Compliance for Medical Device Companies in the AI Age

San Francisco, CA / In-person / January 13, 2026

McDermott Forum at the 2026 J.P. Morgan Healthcare Conference

Dallas, TX / In-person / December 4, 2025

Health Innovators Holiday Celebration 2025

Dallas, TX / In-person / November 20, 2025

BIO BREAK: Dallas’ Monthly Life Sciences Happy Hour

Boston, MA / In-person / November 13, 2025

Life Sciences Investment Forum 2025